Sheboygan Phyisicans Group

Summary

Sheboygan Phyisicans Group is a medical facility located in Sheboygan, Wisconsin. This center is recognized for care of Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer, Lung Cancer and other specialties. Sheboygan Phyisicans Group is involved with conducting 2 clinical trials across 20 conditions. There are 4 research doctors associated with this hospital, such as Matthew L. Ryan, Brian L. Burnette, Anthony J. Jaslowski, and Catherine A. Long.

Top PIs

Clinical Trials running at Sheboygan Phyisicans Group

Breast Cancer

Cancer

Breast cancer

Ovarian Cancer

Prostate Cancer

Colon Cancer

Endometrial Cancer

Solid Tumors

Prostate Adenocarcinoma

Lobular Carcinoma in Situ

Hormone Therapy with or without Radiation

for Breast Cancer

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.

Recruiting

2 awards

Phase 3

13 criteria

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.

Recruiting

2 awards

Phase 3

19 criteria

Radiation and HER2-Targeted Therapy

for Breast Cancer

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.

Recruiting

2 awards

Phase 3

15 criteria